Association Between Adjuvant Therapy and Survival in Stage II-III Endometrial Cancer: Influence of Malignant Peritoneal Cytology.

Koji MatsuoShinya MatsuzakiDavid J NusbaumLynda D RomanJason D WrightPhilipp HarterMaximilian Klar

Published in: Annals of surgical oncology (2021)

Malignant peritoneal cytology is prevalent and prognostic in stage II-III endometrial cancer. This study found that the surgeon's choice and benefit of adjuvant therapy for women with stage II-III endometrial cancer differed depending on the status of peritoneal cytology.

Keyphrases

endometrial cancer
fine needle aspiration
high grade
ultrasound guided
robot assisted